BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4110639)

  • 1. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives.
    Patterson D; Slack J
    Lancet; 1972 Feb; 1(7747):393-9. PubMed ID: 4110639
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipids and lipoproteins in first degree relatives of young survivors of myocardial infarction.
    Aro A
    Acta Med Scand Suppl; 1973; 553():1-103. PubMed ID: 4550038
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
    Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
    Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence and type distribution of hyperlipoproteinemias in hospitalized patients of a university hospital].
    Schlierf G; Weinans G; Weinans T; Reinheimer W; Kahlke W
    Dtsch Med Wochenschr; 1972 Sep; 97(37):1371-5. PubMed ID: 5055723
    [No Abstract]   [Full Text] [Related]  

  • 5. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
    Aubry F; Lapierre YL; Noël C; Davignon J
    Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
    [No Abstract]   [Full Text] [Related]  

  • 6. [Coincidence of disorders in carbohydrate metabolism and types of hyperlipoproteinemias in patients with myocardial infarct].
    von Löwis P; Klemens UH
    Arzneimittelforschung; 1972 Oct; 22(10):1819-23. PubMed ID: 4678572
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevalence of hyperlipoproteinemia during the course of recent myocardial infarct].
    Pagnan A; Donadon W
    Cardiol Prat; 1972; 23(3):237-41. PubMed ID: 4654839
    [No Abstract]   [Full Text] [Related]  

  • 8. [Incidence of hyperlipoproteinemia and other risk factors in chronic and acute phases of patients with myocardial infarct].
    Diehl HJ; Sorge F; Hoffmann H; Weidener J; Schloss W; Schwartzkopff W
    Arzneimittelforschung; 1972 Oct; 22(10):1815-8. PubMed ID: 4678571
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial hyper-pre-betalipoproteinemia with observations on the metabolism of endogenous particles.
    Rose HG
    J Lab Clin Med; 1970 Jul; 76(1):92-102. PubMed ID: 5425367
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)].
    Loeper J; Rouffy J; Loeper J
    Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789
    [No Abstract]   [Full Text] [Related]  

  • 11. Type IV hyperlipoproteinaemia. A survey based on 23 cases.
    Christensen NC; Horder M
    Dan Med Bull; 1970 Feb; 17(2):54-9. PubMed ID: 5446368
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperlipoproteinemia and coronary disease. Occurrence, distribution of types, age and sex factors].
    Klemens UH; von Löuis of Menar P; Bremer A; von Wnuck E; Schröder R
    Klin Wochenschr; 1972 Feb; 50(3):139-48. PubMed ID: 5014941
    [No Abstract]   [Full Text] [Related]  

  • 14. Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia.
    Goldman JA; Glueck CJ; Abrams NR; Steiner P; Herman JH
    Lancet; 1972 Sep; 2(7775):449-52. PubMed ID: 4115343
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum lipids and lipoprotein following acute myocardial infarction in women.
    Birchwood B
    Nutr Metab; 1972; 14(1):38-47. PubMed ID: 4338729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frequency of abnormal lipid values and of hyperlipoproteinaemia in in-patients of a general hospital (author's transl)].
    Schräpler P; Petrides P; Schmidt FH; el-Hamalawi J; Stork H
    Dtsch Med Wochenschr; 1974 Aug; 99(34):1682-6. PubMed ID: 4368141
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperlipoproteinaemia in gout.
    Bluestone R; Lewis B; Mervart I
    Ann Rheum Dis; 1971 Mar; 30(2):134-7. PubMed ID: 5569433
    [No Abstract]   [Full Text] [Related]  

  • 18. [Epidemiological study of disorders of blood lipid equilibrium in the urban population (study of 7085 persons)].
    Mincu I; Cämpeanu S; Dumitrescu C; Mihaiache N; Stănescu V; Georgescu S; Mironescu M; Aron L; Bruckner I
    Med Interna (Bucur); 1972 May; 24(5):583-606. PubMed ID: 5049870
    [No Abstract]   [Full Text] [Related]  

  • 19. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
    Roe DA
    Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
    Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
    Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.